Skip to main content
    N

    NLS Pharmaceutics AG (NLSP)

    BIOTECHNOLOGY

    $2.61
    -0.23 (-8.10%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Oct 6
    		$-1.05$0.00N/AMiss-94.4%
    Mar 25
    Reported May 16
    		$-0.99$0.00N/AMiss+1.0%
    Sep 24
    Reported Oct 18
    		$-1.94$0.00N/AMiss-361.9%
    Mar 23
    Reported May 5
    		$-0.33$0.00N/AMiss-37.5%
    Sep 22
    Reported Oct 11
    		$-0.54$0.00N/AMiss-159.7%
    Dec 21
    Reported Mar 24
    		$-1.00$0.00N/AMiss-96.1%
    Jun 21
    Reported Sep 28
    		$-0.42$0.00N/AMiss-259.0%
    Mar 21
    Reported May 14
    		$-0.24$0.00N/AMiss-171.2%
    Dec 20
    Reported Feb 1
    		$-0.21$0.00N/AMiss+35.0%
    Sep 20
    Reported Oct 19
    		$-0.51$0.00N/AMiss-249.6%
    Jun 20
    Reported Sep 30
    		$-0.12$0.00N/AMiss+19.8%
    Mar 20
    Reported Jun 29
    		$-0.09$0.00N/AMiss+65.2%
    Dec 19
    Reported Feb 28
    		$-0.32$0.00N/AMiss-25.8%
    Sep 19
    Reported Dec 31
    		$-0.15$0.00N/AMiss+39.6%
    Jun 19
    Reported Sep 30
    		$-0.15$0.00N/AMiss+39.6%
    Mar 19
    Reported Jun 29
    		$-0.25$0.00N/AMiss-49.9%
    Dec 18
    Reported Mar 31
    		$-0.25$0.00N/AMiss-49.9%
    Sep 18
    Reported Dec 31
    		$-0.24$0.00N/AMiss-
    Jun 18
    Reported Sep 30
    		$-0.24$0.00N/AMiss-
    Mar 18
    Reported Jun 29
    		$-0.17$0.00N/AMiss-
    Dec 17
    Reported Mar 31
    		$-0.17$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.77xQuick Ratio2.77x
    Trading Statistics
    BetaN/AAvg Volume5.28K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.91
    SMA 20$2.97
    SMA 50$3.19
    SMA 200$3.08
    EMA 10$2.90
    EMA 20$2.98
    EMA 50$3.16
    EMA 200$4.62

    MACD

    Line: -0.11Signal: -0.10Hist: -0.01

    ADX

    ADX: 11.1+DI: 28.6-DI: 25.0

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$3.28

    Bollinger Bands

    Upper Band$3.27
    Lower Band$2.66
    %B Position2070%(Upper)
    Band Width-0.08

    RSI (14-Day)

    Neutral
    32.7

    Momentum Oscillators

    Stoch %K15.0
    Stoch %D30.1
    Williams %R-100.0
    ROC (10d)-15.1%
    Momentum-0.47
    CCI (20d)-171.3
    MFI (14d)58.6

    Volatility Measures

    ATR (14d)$0.23(8.8%)
    StdDev (20d)0.15
    Hist Vol59.0%(High)

    Volume Flow

    VWAP$2.70
    OBV26.9M
    AD Line19.6B
    CMF (20d)-0.043

    Volume Metrics

    Avg Vol (20d)5.4K
    Vol Ratio1.7x(High)
    VWMA (20d)$2.97

    Pivot Points

    R3$3.62
    R2$3.45
    R1$3.15
    Pivot Point$2.97
    S1$2.67
    S2$2.49
    S3$2.19

    Advanced Oscillators

    TSI-18.17
    Ultimate Osc33.7
    KST-108.81

    Financial Data

    QuarterSep 2025Mar 2025Sep 2024Mar 2024Jun 2023Mar 2023Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
    Total RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Cost of Revenue$1,986$-2,383$5,704$5,704$5,704$5,704$5,704N/AN/A$5,028N/A$5,022
    Gross Profit$-1,986$2,383$-5,704$-5,704$-5,704$-5,704$-5,704N/AN/A$-5,028N/A$-5,022
    Operating Expenses$1.78M$1.58M$2.05M$4.26M$7.54M$6.79M$8.68MN/AN/A$7.31MN/A$4.54M
    R&D$142,083$150,701$271,350$1,524$4.38M$3.43M$5.54M$0$0$4.06M$0$1.86M
    SG&A$0$1.43M$1,782$2,732$3,165$3,361$3,143$0$0$3,261$0$2,680
    Operating Income$-1,779,215$-2,326,621$-2,053,491$-4,257,580$-7,549,480$-6,794,340$-8,688,030N/AN/A$-7,317,870N/A$-4,542,750
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$385$63,032$86,985$145,024$129$91,686$9,180$0$0$1$0$68,133
    Income Before Tax$-2,220,671$55,024$-2,035,834$-4,559,290$-7,612,739$-7,854,871$-8,640,809$0$0$-7,342,736$0$-4,603,342
    Income Tax Expense$0$0$104,640$-4$-4$-4$-4$0$0$0$0$-2
    Net Income$-2,220,671$55,024$-2,035,834$-4,559$-7,612,739$-7,854,871$-8,640,809N/AN/A$-7,342,736N/A$-4,603,342
    EBITDA$-2,218,298$-1,585,166$-1,943,147$-4,408,566$-7,543,780$-6,788,640$-8,682,330N/AN/A$-7,337,710N/A$-4,537,730
    EBIT$-2,220,284$-1,582,783$-1,948,851$-4,408,571$-7,549,484$-6,794,344$-8,688,034$-4,344,013$-4,344,013$-7,342,738$-3,658,934$-4,542,752
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NLSP

    News

    No news available

    Company news will appear here when available

    NLSP Valuation and Fair Value

    P/B
    3.6x
    See GNG's fair value

    NLSP Competitors

    CompanyTicker
    Cytosorbents CrpCTSO
    CytoMed Therapeutics Limited Ordinary SharesGDTC
    Phio Pharmaceuticals CorpPHIO
    Biovie IncBIVI
    Ensysce Biosciences IncENSC
    Lantern Pharma IncLTRN
    Kiora Pharmaceuticals IncKPRX
    Bullfrog AI Holdings, Inc. Common StockBFRG

    Sector: Healthcare

    NLSP Bull Case vs Bear Case

    Bear case

    • NLSP beat EPS estimates in 0.0% of its last 8 reported quarters.

    NLSP Earnings: Beat Rate and Next Report

    Beat rate
    0 of 8 quarters (0.0%)

    Frequently Asked Questions About NLSP

    Does NLSP pay dividends?

    NLS Pharmaceutics AG (NLSP) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In